PHILADELPHIA — (JAN. 12, 2023) — Maureen Murphy, Ph.D., has been named Deputy Director of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. Murphy will guide the growth of the Canc…
PHILADELPHIA — (DECEMBER 14, 2022) — The Wistar Institute Biomedical Technician Training (BTT) Program was awarded Workforce Champion of the Year in the 3rd Annual 2022 BioBuzz Awards. The program …
PHILADELPHIA — (DECEMBER 1, 2022) — The National Science Foundation (NSF) has granted a Research Experiences for Undergraduates (REU) grant to The Wistar Institute’s Hubert J.P. Schoemaker Educatio…
PHILADELPHIA — (OCTOBER 24, 2022) — The Wistar Institute, a leader in biomedical breakthroughs headquartered in Philadelphia, is one of the nation’s top drivers of innovation, research, and tech tr…
PHILADELPHIA—(October 20, 2022)— William Way Community Center, Philadelphia FIGHT, BEAT-HIV Delaney Collaboratory, Philadelphia Foundation, The Penn Center for AIDS Research, and The Wistar Institu…
PHILADELPHIA — (OCTOBER 12, 2022) — The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism. In a research paper published in P…
PHILADELPHIA — (OCTOBER 4, 2022) — The National Institutes of Health has awarded Amelia Escolano, Ph.D., assistant professor in The Wistar Institute’s Vaccine & Immunotherapy Center, the 2022 N…
New research finds biological processes that improve prediction of therapeutic performance and provide a framework to develop predictors for this aggressive skin cancer. PHILADELPHIA — (SEPTEMBER 1…
PHILADELPHIA—(September 8, 2022)—The Wistar Institute is pleased to announce the appointment of Michele A. Schiavoni, M.S., as Vice President of Communications & Marketing, in a central leaders…
PHILADELPHIA — (Sept. 7, 2022) — Researchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therapeutics Inc. have uncovered a novel mechani…
